Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

392

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Asthma
Interventions
DRUG

tiotropium high dose

2 actuations once daily

DRUG

placebo

2 actuations once daily

DRUG

tiotropium low dose

2 actuations once daily

Trial Locations (69)

Unknown

205.456.01004 Boehringer Ingelheim Investigational Site, Stockton

205.456.01008 Boehringer Ingelheim Investigational Site, Normal

205.456.01003 Boehringer Ingelheim Investigational Site, Baltimore

205.456.01007 Boehringer Ingelheim Investigational Site, Columbia

205.456.01002 Boehringer Ingelheim Investigational Site, Bellevue

205.456.01001 Boehringer Ingelheim Investigational Site, Rockville Centre

205.456.01005 Boehringer Ingelheim Investigational Site, Cincinnati

205.456.01006 Boehringer Ingelheim Investigational Site, Summerville

205.456.54002 Boehringer Ingelheim Investigational Site, Capital Federal

205.456.54006 Boehringer Ingelheim Investigational Site, Capital Federal

205.456.54008 Boehringer Ingelheim Investigational Site, Capital Federal

205.456.54005 Boehringer Ingelheim Investigational Site, Mendoza

205.456.54003 Boehringer Ingelheim Investigational Site, San Juan Bautista

205.456.54004 Boehringer Ingelheim Investigational Site, San Miguel de Tucumán

205.456.54009 Boehringer Ingelheim Investigational Site, San Miguel de Tucumán

205.456.61002 Boehringer Ingelheim Investigational Site, Parkville

205.456.61001 Boehringer Ingelheim Investigational Site, Perth

205.456.35902 Boehringer Ingelheim Investigational Site, Plovdiv

205.456.35901 Boehringer Ingelheim Investigational Site, Rousse

205.456.35903 Boehringer Ingelheim Investigational Site, Sofia

205.456.49008 Boehringer Ingelheim Investigational Site, Berlin

205.456.49001 Boehringer Ingelheim Investigational Site, Bochum

205.456.49004 Boehringer Ingelheim Investigational Site, Frankfurt

205.456.49005 Boehringer Ingelheim Investigational Site, Kehl

205.456.49003 Boehringer Ingelheim Investigational Site, Koblenz

205.456.49010 Boehringer Ingelheim Investigational Site, Mainz

205.456.49007 Boehringer Ingelheim Investigational Site, Neu-Isenburg

205.456.49002 Boehringer Ingelheim Investigational Site, Wesel

205.456.50201 Boehringer Ingelheim Investigational Site, Guatemala City

205.456.50203 Boehringer Ingelheim Investigational Site, Guatemala City

205.456.50204 Boehringer Ingelheim Investigational Site, Guatemala City

205.456.50205 Boehringer Ingelheim Investigational Site, Guatemala City

205.456.36005 Boehringer Ingelheim Investigational Site, Budapest

205.456.36002 Boehringer Ingelheim Investigational Site, Debrecen

205.456.36004 Boehringer Ingelheim Investigational Site, Gyula

205.456.36001 Boehringer Ingelheim Investigational Site, Miskolc

205.456.36007 Boehringer Ingelheim Investigational Site, Mosdós

205.456.36006 Boehringer Ingelheim Investigational Site, Nagyatád

205.456.97205 Boehringer Ingelheim Investigational Site, Holon

205.456.97203 Boehringer Ingelheim Investigational Site, Petah Tikva

205.456.97201 Boehringer Ingelheim Investigational Site, Safed

205.456.37101 Boehringer Ingelheim Investigational Site, Baldone

205.456.37104 Boehringer Ingelheim Investigational Site, Balvi

205.456.37103 Boehringer Ingelheim Investigational Site, Rēzekne

205.456.37102 Boehringer Ingelheim Investigational Site, Riga

205.456.37105 Boehringer Ingelheim Investigational Site, Talsi

205.456.52001 Boehringer Ingelheim Investigational Site, Hermosillo Sonora

205.456.52002 Boehringer Ingelheim Investigational Site, Monterrey

205.456.52003 Boehringer Ingelheim Investigational Site, Monterrey

205.456.52004 Boehringer Ingelheim Investigational Site, Nuevo León

205.456.09001 Boehringer Ingelheim Investigational Site, Quezon City

205.456.09002 Boehringer Ingelheim Investigational Site, Quezon City

205.456.35105 Boehringer Ingelheim Investigational Site, Coimbra

205.456.35101 Boehringer Ingelheim Investigational Site, Lisbon

205.456.35102 Boehringer Ingelheim Investigational Site, Lisbon

205.456.35104 Boehringer Ingelheim Investigational Site, Lisbon

205.456.35103 Boehringer Ingelheim Investigational Site, Porto

205.456.27001 Boehringer Ingelheim Investigational Site, Cape Town

205.456.27002 Boehringer Ingelheim Investigational Site, Durban

205.456.38006 Boehringer Ingelheim Investigational Site, Dnipropetrovsk

205.456.38004 Boehringer Ingelheim Investigational Site, Kharkiv

205.456.38003 Boehringer Ingelheim Investigational Site, Kiev

205.456.38010 Boehringer Ingelheim Investigational Site, Kryvyi Rih

205.456.38009 Boehringer Ingelheim Investigational Site, Kyiv

205.456.38001 Boehringer Ingelheim Investigational Site, Lviv

205.456.38007 Boehringer Ingelheim Investigational Site, Lviv

205.456.38005 Boehringer Ingelheim Investigational Site, Uzhhorod

205.456.38008 Boehringer Ingelheim Investigational Site, Vinnytsia

205.456.38002 Boehringer Ingelheim Investigational Site, Zaporizhzhya

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY